James Hanley

James Hanley (for more see his website http://www.biostat.mcgill.ca/hanley ) is a biostatistician who began his career in clinical trials of cancer treatments. He joined McGill in 1980, where he first worked on developing statistical methods to evaluate the accuracy of medical diagnostic tests. In the 90s he helped the Quebec Council for Technology Evaluation advise the Health Ministry on whether it should pay fo PSA tests for earlier detection of prostate cancer. Since then his interests have broadened to cancer screening more generally, and in particular to statistical models that help measure the mortality reductions it produces. He has taught extensively and collaborated widely on topics from paediatrics to geriatrics. He has been a consultant to several agencies, including, most recently, the World Anti-Doping Agency. He has also written several expository articles on statistics, and has a growing interest in the history of epidemiology and statistics.